Target intelligence / Profile preview

Cytoplasmic linker protein 1 (CLIP1)

Target
CLIP1
Molecular classification
Microtubule-plus-end-tracking protein, Cytoskeletal protein, Linker protein
01

Overview

Cytoplasmic linker protein 1 (CLIP1), also known as CLIP-170, is a member of the microtubule-plus-end-tracking proteins (+TIPs) that plays a fundamental role in regulating microtubule dynamics and linking cellular organelles to the cytoskeleton (UniProt: P30622). It facilitates the initiation of microtubule growth and is essential for the recruitment of the dynein-dynactin complex to microtubule ends, which is critical for retrograde transport and cell migration (PubMed: 10531020). During mitosis, CLIP1 is required for stable kinetochore-microtubule attachments and proper spindle assembly, ensuring the high fidelity of chromosome segregation (PubMed: 15632202). In clinical oncology, CLIP1 is recognized as a significant fusion partner for the Anaplastic Lymphoma Kinase (ALK) gene; the resulting CLIP1-ALK fusion acts as an oncogenic driver in non-small cell lung cancer (NSCLC) and is a validated target for ALK tyrosine kinase inhibitors (PubMed: 29330158). Beyond cancer, germline mutations in the CLIP1 gene have been identified as a cause of autosomal recessive primary microcephaly, underscoring its vital role in brain development and neuronal proliferation (PubMed: 25944325). While CLIP1 is not typically the primary target of small molecules, its involvement in microtubule stability makes it a key factor in determining cellular sensitivity to microtubule-targeting agents like taxanes.

Other names
CLIP-170RestinRSNCLIP170Cytoplasmic linker protein 170 kDa
02

Mechanism of action

Inhibition of the tyrosine kinase activity of CLIP1-ALK fusion proteins to disrupt oncogenic signaling pathways.

03

Biological functions

Microtubule dynamics regulationOrganelle transportCell migrationMitotic spindle assemblyKinetochore-microtubule attachmentRetrograde transport recruitment
04

Disease associations

Non-small cell lung cancerAutosomal recessive primary microcephalyBreast cancerNeurodevelopmental disorders
05

Safety considerations

Potential neurotoxicity due to disruption of neuronal microtubule transportRisk of mitotic errors in healthy dividing cellsTherapeutic resistance through secondary mutations in fusion partners
06

Interacting drugs

Crizotinib

4 more in the full profile.

07

Biomarkers

CLIP1-ALK fusion transcriptCLIP1 protein expression levelsCLIP1-ROS1 fusion

Beyond the preview

Go deeper on Cytoplasmic linker protein 1 (CLIP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytoplasmic linker protein 1 (CLIP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call